The chronic myeloid leukaemias: Guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia. Proposals by the French-American-British Cooperative Leukaemia Group
Bennett JM, Catovsky D, Daniel MT, et al. The chronic myeloid leukaemias: guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia. Proposals by the French-American-British Cooperative Leukaemia Group. Br J Haematol 1994; 87:746-54.
New insights in biology and current therapeutic options for patients with chronic myelogenous leukemia
Carella AM, Frassoni F, Melo J, et al. New insights in biology and current therapeutic options for patients with chronic myelogenous leukemia. Haematologica 1997; 82:478-95.
Fusion of PDGF receptor β to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation
Golub TR, Barker GF, Lovett M, Gilliland DG. Fusion of PDGF receptor β to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell 1994; 77:307-16.
Fusion of Huntington interacting protein 1 to platelet-derived growth factor β receptor (PDGFβR) in chronic myelomonocytic leukemia with t(5;7)(q33;q11.2)
Ross ST, Bernard O, Berger R, Gilliland DG. Fusion of Huntington interacting protein 1 to platelet-derived growth factor β receptor (PDGFβR) in chronic myelomonocytic leukemia with t(5;7)(q33;q11.2). Blood 1998; 91:4419-26.
Fusion of the platelet-derived growth factor receptor β to a novel CEV14 in acute myelogenous leukemia after clonal evolution
Abe A, Emi N, Tanimoto M, Terasaki H, Marunouchi T, Saito H. Fusion of the platelet-derived growth factor receptor β to a novel CEV14 in acute myelogenous leukemia after clonal evolution. Blood 1997; 90:4271-7.
Selection of myeloid progenitors lacking BCR-ABL mRNA in chronic myelogenous leukemia patients after in vitro treatment with the tyrosine kinase inhibitor genistein
Carlo-Stella C, Dotti G, Mangoni L, et al. Selection of myeloid progenitors lacking BCR-ABL mRNA in chronic myelogenous leukemia patients after in vitro treatment with the tyrosine kinase inhibitor genistein. Blood 1996; 88:3091-100.
Absence of variable transcription of BCR-ABL by Philadelphia-positive progenitors from mononuclear and CD34+ cells
Savoldo B, Sammarelli G, Garau D, et al. Absence of variable transcription of BCR-ABL by Philadelphia-positive progenitors from mononuclear and CD34+ cells. Leukemia 1998; 12:434-40.